India OTC Market: $10.7bn Opportunity Awaits Pharma, But Will Regulatory Reform Flow?
Huge opportunities for OTC therapies loom in India, as consumerization brings structural reset in healthcare. Success stories on Rx-to-OTC transition augur well for pharma, but a predictable regulatory roadmap will be pivotal for sustainable growth.

















